Hydrocephalus Complicating Intrathecal Antisense Oligonucleotide Therapy for Huntington's Disease
Sign Up to like & getrecommendations! Published in 2020 at "Movement Disorders"
DOI: 10.1002/mds.28359
Abstract: Funding sources and conflict of interest – This trial was funded initially by Ionis and subsequently by Roche. The authors received no additional funding for this work and the authors declare that there are no… read more here.
Keywords: oligonucleotide therapy; complicating intrathecal; antisense oligonucleotide; hydrocephalus complicating ... See more keywords